TRCT
TYRA icon

Tower Research Capital (TRC)’s Tyra Biosciences TYRA Stock Holding History

Tower Research Capital (TRC)’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.6K Sell
2,930
-75
-2% -$2.48K ﹤0.01% 2236
2026
Q1 		$115K Buy
3,005
+2,674
+808% +$86.6K ﹤0.01% 2074
2025
Q4 		$8.7K Sell
331
-543
-62% -$9.97K ﹤0.01% 3938
2025
Q3 		$12.2K Sell
874
-1,966
-69% -$22.4K ﹤0.01% 3809
2025
Q2 		$27.2K Buy
2,840
+757
+36% +$7.19K ﹤0.01% 3478
2025
Q1 		$19.4K Buy
2,083
+666
+47% +$8.62K ﹤0.01% 3000
2024
Q4 		$19.7K Buy
1,417
+206
+17% +$3.74K ﹤0.01% 3196
2024
Q3 		$28.5K Sell
1,211
-966
-44% -$20.3K ﹤0.01% 3034
2024
Q2 		$34.8K Buy
2,177
+2,033
+1,412% +$35K ﹤0.01% 3374
2024
Q1 		$2.36K Sell
144
-860
-86% -$14.1K ﹤0.01% 5059
2023
Q4 		$13.9K Buy
1,004
+146
+17% +$1.89K ﹤0.01% 3924
2023
Q3 		$11.8K Buy
858
+200
+30% +$2.97K ﹤0.01% 3955
2023
Q2 		$11.2K Sell
658
-888
-57% -$12.9K ﹤0.01% 4004
2023
Q1 		$25K Sell
1,546
-347
-18% -$4.13K ﹤0.01% 3219
2022
Q4 		$14K Sell
1,893
-2,310
-55% -$16.3K ﹤0.01% 3539
2022
Q3 		$37K Buy
4,203
+1,266
+43% +$11.6K ﹤0.01% 3440
2022
Q2 		$21K Buy
2,937
+1,694
+136% +$13.5K ﹤0.01% 3762
2022
Q1 		$13K Buy
1,243
+280
+29% +$3.32K ﹤0.01% 4003
2021
Q4 		$14K Buy
+963
New +$19.1K ﹤0.01% 4110

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Tower Research Capital (TRC)'s TYRA Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Tyra Biosciences (TYRA) stake by 2.5% in Q2 2026, selling an estimated $2.48K and leaving 2,930 shares worth $93.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2236.

Tower Research Capital (TRC) first reported a position in TYRA in Q4 2021 and has held it in 19 quarters since. The position peaked at $115K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Tower Research Capital (TRC) held 2,930 shares of Tyra Biosciences worth $93.6K as of Q2 2026.
  • Tower Research Capital (TRC) sold 75 Tyra Biosciences shares in Q2 2026, an estimated $2.48K.
  • Tyra Biosciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2236 holding.
  • Tower Research Capital (TRC) first reported a position in Tyra Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Tyra Biosciences position peaked at $115K in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.